SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-066646
Filing Date
2023-05-31
Accepted
2023-05-31 16:40:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2317293d1_424b5.htm 424B5 325044
2 GRAPHIC tm2317293d1_424b5img001.jpg GRAPHIC 4615
3 GRAPHIC tm2317293d1_424b5img002.jpg GRAPHIC 4615
  Complete submission text file 0001104659-23-066646.txt   339171
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239473 | Film No.: 23981577
SIC: 2834 Pharmaceutical Preparations